Test-No Test Implantable Cardioverter Defibrillator Pilot Study (TNT-ICD)

Status: Unknown status
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The primary objective of this study is to compare the composite outcome of total mortality and operative complications in patients who do not undergo defibrillation testing to those who do undergo defibrillation testing at the time of initial ICD implantation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• Age ≥ 18 years

• Initial ICD implantation (single, dual, or CRT) for a standard Class I or Class II indication according to the ACC/AHA/HRS practice guidelines

• Anticipated life expectancy >6 months

Locations
United States
New Jersey
Cooper University Hospital
Recruiting
Camden
Washington
University of Washington
Not yet recruiting
Seattle
Contact Information
Primary
Andrea M. Russo, MD
russo-andrea@cooperhealth.edu
856-968-7096
Backup
Julie Field
field-julie@cooperhealth.edu
856-669-8847
Time Frame
Start Date: December 2010
Completion Date: December 2014
Participants
Target number of participants: 100
Treatments
Active Comparator: Defibrillation testing
Defibrillation testing at initial ICD implantation
No Intervention: No defibrillation testing
No defibrillation testing at initial ICD implantation
Authors
Matthew Ortman, Jeanne Poole, John Andriulli, Claudine Pasquarello, Andrea M. Russo
Sponsors
Collaborators: Medtronic, University of Washington
Leads: The Cooper Health System

This content was sourced from clinicaltrials.gov

Similar Clinical Trials